Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to gain more insight into the potential impact of a vitrectomy (removal of the vitreous) on postoperative effective position of the intraocular lens (IOL). Moreover, this study can provide very useful information for the optimal lens calculation in patients undergoing lens extraction with IOL implantation (whether or not combined with a vitrectomy) should undergo.


Clinical Trial Description

- Comparison ELP post phaco VTX (pucker / floaters) versus post phaco and use this information to develop a customized IOL calculation for eyes undergoing phacoVTX.

- Evidence for recording lens thickness (LT) parameter in the IOL strength calculation in KWS (in the calculation of the ELP in the light of the Olsen formula, using the C-constant) in order to be able to make an even more accurate prediction of the post-operative diopter target of the patient. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04397068
Study type Interventional
Source Universitaire Ziekenhuizen Leuven
Contact
Status Completed
Phase N/A
Start date March 1, 2016
Completion date March 31, 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01969929 - Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy N/A
Completed NCT00555269 - Membrane Blue Versus Infracyanine Green N/A
Completed NCT03934190 - Inner Nuclear Macular Microcyst is a Risk Factor for Macular Cystoid Changes After Phacoemulsification in Eyes With Previous Vitrectomy and Macular Pucker Removal
Terminated NCT04802265 - EpiRetinal Membrane Peeling and Internal Limiting Membrane
Completed NCT02319655 - Morphologic Changes After Membrane Peeling With Air Tamponade and Balanced Salt Solution N/A
Completed NCT05517473 - Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains
Completed NCT01162356 - Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study N/A
Recruiting NCT01083004 - Brilliant Blue Versus Indocyanine Green Phase 3
Recruiting NCT04802915 - Intraoperative Analysis of the Central Retina in ERF N/A
Recruiting NCT04501367 - Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker. Phase 4
Recruiting NCT05860985 - Zeiss RESIGHT Disposable Lenses Evaluation Study N/A